Skip to main content
Menu
US
future-of-immunotherapy-with-base-editing-literature-review1920x640
Literature - Publication Review

The future of immunotherapy gets brighter with base editing

Discover how base editing technology is helping to address the shortcomings of other gene editing technologies for immunotherapy in this literature review.

In this literature review, you will learn about…

  • An overview and comparison of autologous and allogeneic CAR-T therapies
  • Safety concerns relating to gene editing
  • How base editing alleviates safety concerns of other gene editing technologies for immunotherapy

The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

The future of immunotherapy gets brighter with base editing